

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 4.39499692 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 4.39499692 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.39499692 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.39499692 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.39499692 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.39499692 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.35817475 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.25916979 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 4.08817026 |
| 10 | kynurenine metabolic process (GO:0070189) | 3.75753869 |
| 11 | positive regulation of antigen processing and presentation (GO:0002579) | 3.75518153 |
| 12 | response to peptidoglycan (GO:0032494) | 3.70651942 |
| 13 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.67182284 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.66712477 |
| 15 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.54557865 |
| 16 | respiratory burst (GO:0045730) | 3.50808035 |
| 17 | regulation of antigen processing and presentation (GO:0002577) | 3.48471326 |
| 18 | positive regulation of interferon-alpha production (GO:0032727) | 3.46486770 |
| 19 | positive regulation of defense response to virus by host (GO:0002230) | 3.44708450 |
| 20 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.41202390 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 3.38422898 |
| 22 | positive regulation of heat generation (GO:0031652) | 3.38356688 |
| 23 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.30941507 |
| 24 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.30631932 |
| 25 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.30081355 |
| 26 | regulation of chronic inflammatory response (GO:0002676) | 3.29639039 |
| 27 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.29315140 |
| 28 | regulation of interferon-alpha production (GO:0032647) | 3.26364202 |
| 29 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.26256366 |
| 30 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.22275985 |
| 31 | cellular biogenic amine catabolic process (GO:0042402) | 3.19664826 |
| 32 | amine catabolic process (GO:0009310) | 3.19664826 |
| 33 | microglial cell activation (GO:0001774) | 3.19222127 |
| 34 | detection of molecule of bacterial origin (GO:0032490) | 3.16784104 |
| 35 | indolalkylamine metabolic process (GO:0006586) | 3.15950323 |
| 36 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.15615201 |
| 37 | superoxide anion generation (GO:0042554) | 3.10269479 |
| 38 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.06056144 |
| 39 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.02484196 |
| 40 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99417213 |
| 41 | amyloid precursor protein catabolic process (GO:0042987) | 2.99315911 |
| 42 | neutrophil activation (GO:0042119) | 2.99017843 |
| 43 | oligosaccharide catabolic process (GO:0009313) | 2.98844422 |
| 44 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.95479333 |
| 45 | granulocyte activation (GO:0036230) | 2.95150354 |
| 46 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.93125080 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 2.92203617 |
| 48 | eosinophil chemotaxis (GO:0048245) | 2.92050811 |
| 49 | macrophage activation (GO:0042116) | 2.91755332 |
| 50 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.91717765 |
| 51 | response to protozoan (GO:0001562) | 2.89905916 |
| 52 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.88891752 |
| 53 | response to host immune response (GO:0052572) | 2.87515290 |
| 54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.87515290 |
| 55 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.86189153 |
| 56 | regulation of mononuclear cell migration (GO:0071675) | 2.85415079 |
| 57 | cellular response to exogenous dsRNA (GO:0071360) | 2.84863178 |
| 58 | regulation of interleukin-12 production (GO:0032655) | 2.83020012 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.82996038 |
| 60 | defense response to protozoan (GO:0042832) | 2.81003533 |
| 61 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.80553855 |
| 62 | regulation of fever generation (GO:0031620) | 2.78237763 |
| 63 | regulation of heat generation (GO:0031650) | 2.78178480 |
| 64 | reactive oxygen species biosynthetic process (GO:1903409) | 2.76286521 |
| 65 | regulation of vitamin metabolic process (GO:0030656) | 2.75300065 |
| 66 | complement activation, alternative pathway (GO:0006957) | 2.74048113 |
| 67 | cellular response to type I interferon (GO:0071357) | 2.73724767 |
| 68 | type I interferon signaling pathway (GO:0060337) | 2.73724767 |
| 69 | pinocytosis (GO:0006907) | 2.73287521 |
| 70 | T-helper 1 type immune response (GO:0042088) | 2.73036057 |
| 71 | myeloid cell activation involved in immune response (GO:0002275) | 2.72906234 |
| 72 | monocyte chemotaxis (GO:0002548) | 2.72229342 |
| 73 | regulation of chemokine biosynthetic process (GO:0045073) | 2.71848406 |
| 74 | response to type I interferon (GO:0034340) | 2.71422913 |
| 75 | response to muramyl dipeptide (GO:0032495) | 2.70519641 |
| 76 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.67868442 |
| 77 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.67435273 |
| 78 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.66711750 |
| 79 | DNA deamination (GO:0045006) | 2.65819001 |
| 80 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.65671519 |
| 81 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.65430585 |
| 82 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.65401846 |
| 83 | glycosphingolipid catabolic process (GO:0046479) | 2.64049848 |
| 84 | negative regulation of interleukin-1 production (GO:0032692) | 2.62607224 |
| 85 | detection of other organism (GO:0098543) | 2.61442641 |
| 86 | positive regulation of mast cell activation (GO:0033005) | 2.61410309 |
| 87 | eosinophil migration (GO:0072677) | 2.60490286 |
| 88 | positive regulation of interleukin-12 production (GO:0032735) | 2.60284365 |
| 89 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.59356826 |
| 90 | B cell mediated immunity (GO:0019724) | 2.59186625 |
| 91 | regulation of hypersensitivity (GO:0002883) | 2.58428116 |
| 92 | regulation of mast cell degranulation (GO:0043304) | 2.58120671 |
| 93 | germinal center formation (GO:0002467) | 2.57686679 |
| 94 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.57464710 |
| 95 | protein carboxylation (GO:0018214) | 2.57464710 |
| 96 | detection of external biotic stimulus (GO:0098581) | 2.56370002 |
| 97 | negative regulation of lipid storage (GO:0010888) | 2.55413407 |
| 98 | positive regulation of natural killer cell activation (GO:0032816) | 2.54164453 |
| 99 | regulation of defense response to virus by host (GO:0050691) | 2.54044562 |
| 100 | regulation of mast cell activation (GO:0033003) | 2.54019354 |
| 101 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.53855374 |
| 102 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.52944492 |
| 103 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.52879644 |
| 104 | positive regulation of T cell migration (GO:2000406) | 2.52634756 |
| 105 | interferon-gamma secretion (GO:0072643) | 2.52530718 |
| 106 | regulation of T-helper 1 type immune response (GO:0002825) | 2.52365158 |
| 107 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.52344514 |
| 108 | tryptophan metabolic process (GO:0006568) | 2.52107034 |
| 109 | NIK/NF-kappaB signaling (GO:0038061) | 2.51315669 |
| 110 | phospholipid efflux (GO:0033700) | 2.50900112 |
| 111 | positive regulation of interleukin-17 production (GO:0032740) | 2.50685631 |
| 112 | positive regulation of interferon-beta production (GO:0032728) | 2.50488886 |
| 113 | negative regulation of mast cell activation (GO:0033004) | 2.50359181 |
| 114 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.49743826 |
| 115 | positive regulation of type 2 immune response (GO:0002830) | 2.49439761 |
| 116 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.48737028 |
| 117 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.48143484 |
| 118 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.47817454 |
| 119 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.47640391 |
| 120 | cellular response to ethanol (GO:0071361) | 2.47288666 |
| 121 | response to interferon-gamma (GO:0034341) | 2.45755840 |
| 122 | glycolipid catabolic process (GO:0019377) | 2.45624733 |
| 123 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.45476403 |
| 124 | L-phenylalanine catabolic process (GO:0006559) | 2.45476403 |
| 125 | regulation of activation of Janus kinase activity (GO:0010533) | 2.45185272 |
| 126 | regulation of gamma-delta T cell activation (GO:0046643) | 2.45041227 |
| 127 | intracellular pH reduction (GO:0051452) | 2.43609129 |
| 128 | cellular response to interferon-gamma (GO:0071346) | 2.43535179 |
| 129 | positive regulation of lymphocyte migration (GO:2000403) | 2.43416852 |
| 130 | aromatic amino acid family catabolic process (GO:0009074) | 2.43287970 |
| 131 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.43035297 |
| 132 | positive regulation of mast cell degranulation (GO:0043306) | 2.43035297 |
| 133 | platelet dense granule organization (GO:0060155) | 2.42111490 |
| 134 | response to interferon-beta (GO:0035456) | 2.42048488 |
| 135 | response to host (GO:0075136) | 2.41825196 |
| 136 | response to host defenses (GO:0052200) | 2.41825196 |
| 137 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.41825196 |
| 138 | regulation of cholesterol esterification (GO:0010872) | 2.41481679 |
| 139 | positive regulation of B cell differentiation (GO:0045579) | 2.41403577 |
| 140 | amyloid precursor protein metabolic process (GO:0042982) | 2.41027826 |
| 141 | indole-containing compound catabolic process (GO:0042436) | 2.39598526 |
| 142 | indolalkylamine catabolic process (GO:0046218) | 2.39598526 |
| 143 | tryptophan catabolic process (GO:0006569) | 2.39598526 |
| 144 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.38719319 |
| 145 | response to thyroid hormone (GO:0097066) | 2.37640498 |
| 146 | regulation of T cell migration (GO:2000404) | 2.37383674 |
| 147 | positive regulation of coagulation (GO:0050820) | 2.36832584 |
| 148 | cholesterol efflux (GO:0033344) | 2.36268622 |
| 149 | plasma lipoprotein particle clearance (GO:0034381) | 2.34896991 |
| 150 | detection of biotic stimulus (GO:0009595) | 2.34782982 |
| 151 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.34613821 |
| 152 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.33094265 |
| 153 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.33094265 |
| 154 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.32381689 |
| 155 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.31621060 |
| 156 | NAD biosynthetic process (GO:0009435) | 2.31430860 |
| 157 | response to interferon-alpha (GO:0035455) | 2.31286195 |
| 158 | myeloid leukocyte activation (GO:0002274) | 2.30718107 |
| 159 | ceramide catabolic process (GO:0046514) | 2.30058953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.48837993 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.17929988 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.02872160 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.68830653 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.57770136 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41845644 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.33272507 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.27389597 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.10323120 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.94293052 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.85388182 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78490608 |
| 13 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.52990808 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43803209 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.37863568 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.36898185 |
| 17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36459710 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.35491934 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.21550627 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.97544942 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88223519 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86588323 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.84254094 |
| 24 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81185390 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.80763337 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.80258453 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.78801689 |
| 28 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77166558 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75307876 |
| 30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.74379779 |
| 31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.69447412 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.65145254 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.62497491 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52498617 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51080305 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.50729820 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50656696 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45499500 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43407684 |
| 40 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43242787 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42624330 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40672428 |
| 43 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.38623642 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.37863478 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37792927 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37497484 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37231613 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37018127 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34951924 |
| 50 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.32827248 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31682241 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27818922 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26286187 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25821316 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25400935 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25350481 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22433446 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20143934 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18464222 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18464222 |
| 61 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.17085668 |
| 62 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16232798 |
| 63 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15347863 |
| 64 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14120160 |
| 65 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.13658988 |
| 66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11427005 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09135381 |
| 68 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08398681 |
| 69 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08235455 |
| 70 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07456432 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06269493 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06183905 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.05672866 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02405704 |
| 75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01835829 |
| 76 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01403957 |
| 77 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00088122 |
| 78 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98841538 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97369017 |
| 80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96962226 |
| 81 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96438420 |
| 82 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96085791 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96076287 |
| 84 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.95615457 |
| 85 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95096608 |
| 86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.94811097 |
| 87 | AR_20517297_ChIP-Seq_VCAP_Human | 0.93216273 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92748012 |
| 89 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91970426 |
| 90 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.91877698 |
| 91 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91765753 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91696382 |
| 93 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90931897 |
| 94 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.89220415 |
| 95 | MYB_26560356_Chip-Seq_TH2_Human | 0.89188480 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88225224 |
| 97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.87369795 |
| 98 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.87369795 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86245196 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86194450 |
| 101 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.85939793 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85675318 |
| 103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85420734 |
| 104 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85406293 |
| 105 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84949115 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83998739 |
| 107 | P300_27268052_Chip-Seq_Bcells_Human | 0.83506329 |
| 108 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.83125732 |
| 109 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.83125732 |
| 110 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82828039 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82553177 |
| 112 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.82521595 |
| 113 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.82345677 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82343126 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81899039 |
| 116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.81339823 |
| 117 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80579778 |
| 118 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79944025 |
| 119 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79815692 |
| 120 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.79433694 |
| 121 | MYB_26560356_Chip-Seq_TH1_Human | 0.78573241 |
| 122 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78048433 |
| 123 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.77995397 |
| 124 | ERA_21632823_ChIP-Seq_H3396_Human | 0.77994167 |
| 125 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77944481 |
| 126 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.77940786 |
| 127 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77879800 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77627111 |
| 129 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.77518592 |
| 130 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.77258590 |
| 131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.76923223 |
| 132 | CJUN_26792858_Chip-Seq_BT549_Human | 0.76415665 |
| 133 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.75116751 |
| 134 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75021271 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74492384 |
| 136 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.73792659 |
| 137 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.73441473 |
| 138 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.72954183 |
| 139 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70144066 |
| 140 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.69950810 |
| 141 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.69870405 |
| 142 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.69391932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.69671422 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.19479463 |
| 3 | MP0003436_decreased_susceptibility_to | 2.75161055 |
| 4 | MP0006082_CNS_inflammation | 2.73309927 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.72336179 |
| 6 | MP0009840_abnormal_foam_cell | 2.71035971 |
| 7 | MP0003724_increased_susceptibility_to | 2.67650617 |
| 8 | * MP0002419_abnormal_innate_immunity | 2.65495207 |
| 9 | MP0009785_altered_susceptibility_to | 2.63914637 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.49905080 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.39634711 |
| 12 | MP0002254_reproductive_system_inflammat | 2.39100890 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.38947590 |
| 14 | MP0001790_abnormal_immune_system | 2.38782603 |
| 15 | MP0005387_immune_system_phenotype | 2.38782603 |
| 16 | MP0005025_abnormal_response_to | 2.37152095 |
| 17 | MP0000685_abnormal_immune_system | 2.19736295 |
| 18 | MP0005671_abnormal_response_to | 2.05078381 |
| 19 | MP0005360_urolithiasis | 2.04990122 |
| 20 | MP0005365_abnormal_bile_salt | 2.01680742 |
| 21 | MP0003195_calcinosis | 2.00275784 |
| 22 | * MP0002452_abnormal_antigen_presenting | 1.94570039 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.91213704 |
| 24 | MP0009764_decreased_sensitivity_to | 1.90650368 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.89496805 |
| 26 | MP0001800_abnormal_humoral_immune | 1.88536822 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.88169713 |
| 28 | MP0002723_abnormal_immune_serum | 1.85710589 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.85607319 |
| 30 | MP0005085_abnormal_gallbladder_physiolo | 1.81970857 |
| 31 | MP0003690_abnormal_glial_cell | 1.74057805 |
| 32 | MP0008469_abnormal_protein_level | 1.73595669 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.70592816 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.69443760 |
| 35 | MP0002277_abnormal_respiratory_mucosa | 1.62193942 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.58347504 |
| 37 | MP0005310_abnormal_salivary_gland | 1.58259333 |
| 38 | * MP0001819_abnormal_immune_cell | 1.54769405 |
| 39 | MP0005083_abnormal_biliary_tract | 1.53875223 |
| 40 | * MP0002420_abnormal_adaptive_immunity | 1.53456416 |
| 41 | MP0002405_respiratory_system_inflammati | 1.49233697 |
| 42 | MP0004782_abnormal_surfactant_physiolog | 1.43956674 |
| 43 | MP0004510_myositis | 1.42939107 |
| 44 | MP0010329_abnormal_lipoprotein_level | 1.40612044 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.40045002 |
| 46 | MP0003303_peritoneal_inflammation | 1.38815958 |
| 47 | MP0000604_amyloidosis | 1.34776030 |
| 48 | MP0008438_abnormal_cutaneous_collagen | 1.33630620 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.33127060 |
| 50 | MP0005451_abnormal_body_composition | 1.33040964 |
| 51 | MP0003186_abnormal_redox_activity | 1.32733670 |
| 52 | MP0004019_abnormal_vitamin_homeostasis | 1.32140465 |
| 53 | MP0004381_abnormal_hair_follicle | 1.28443896 |
| 54 | MP0009278_abnormal_bone_marrow | 1.27383450 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.26340431 |
| 56 | MP0000343_altered_response_to | 1.24664803 |
| 57 | MP0003646_muscle_fatigue | 1.23805565 |
| 58 | MP0003252_abnormal_bile_duct | 1.21275918 |
| 59 | MP0001853_heart_inflammation | 1.20785532 |
| 60 | MP0004947_skin_inflammation | 1.19455825 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.16964143 |
| 62 | MP0009763_increased_sensitivity_to | 1.15092504 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.13214294 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.13214294 |
| 65 | MP0002166_altered_tumor_susceptibility | 1.12067791 |
| 66 | MP0003075_altered_response_to | 1.11955292 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.09284178 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 1.08661000 |
| 69 | MP0006054_spinal_hemorrhage | 1.08626231 |
| 70 | MP0002132_abnormal_respiratory_system | 1.07807320 |
| 71 | MP0000609_abnormal_liver_physiology | 1.07362953 |
| 72 | MP0005332_abnormal_amino_acid | 1.07210170 |
| 73 | * MP0009643_abnormal_urine_homeostasis | 1.06234695 |
| 74 | MP0010386_abnormal_urinary_bladder | 1.05951486 |
| 75 | MP0000716_abnormal_immune_system | 1.05393759 |
| 76 | MP0008260_abnormal_autophagy | 1.04924436 |
| 77 | MP0001666_abnormal_nutrient_absorption | 1.04646893 |
| 78 | MP0002933_joint_inflammation | 1.04166209 |
| 79 | MP0001663_abnormal_digestive_system | 1.03298677 |
| 80 | MP0003300_gastrointestinal_ulcer | 1.02756886 |
| 81 | MP0003448_altered_tumor_morphology | 1.00401161 |
| 82 | MP0005164_abnormal_response_to | 0.99493282 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 0.96997968 |
| 84 | MP0004043_abnormal_pH_regulation | 0.96778349 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 0.96234514 |
| 86 | MP0000858_altered_metastatic_potential | 0.95035044 |
| 87 | MP0005166_decreased_susceptibility_to | 0.93753852 |
| 88 | MP0002693_abnormal_pancreas_physiology | 0.93449713 |
| 89 | MP0002006_tumorigenesis | 0.92897479 |
| 90 | MP0000569_abnormal_digit_pigmentation | 0.92675183 |
| 91 | MP0003183_abnormal_peptide_metabolism | 0.92574008 |
| 92 | MP0001873_stomach_inflammation | 0.92496847 |
| 93 | MP0002332_abnormal_exercise_endurance | 0.92153415 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.91013049 |
| 95 | MP0000920_abnormal_myelination | 0.89853581 |
| 96 | MP0005257_abnormal_intraocular_pressure | 0.87790419 |
| 97 | MP0001764_abnormal_homeostasis | 0.86927448 |
| 98 | MP0000689_abnormal_spleen_morphology | 0.86303424 |
| 99 | MP0005408_hypopigmentation | 0.85429827 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.85351481 |
| 101 | MP0008004_abnormal_stomach_pH | 0.84992005 |
| 102 | MP0005390_skeleton_phenotype | 0.84861300 |
| 103 | MP0001958_emphysema | 0.84307556 |
| 104 | MP0005319_abnormal_enzyme/_coenzyme | 0.84303319 |
| 105 | MP0000015_abnormal_ear_pigmentation | 0.83794789 |
| 106 | MP0003866_abnormal_defecation | 0.82756903 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82328064 |
| 108 | MP0001851_eye_inflammation | 0.79178315 |
| 109 | MP0002429_abnormal_blood_cell | 0.78907459 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.77442358 |
| 111 | MP0000371_diluted_coat_color | 0.77372851 |
| 112 | MP0002295_abnormal_pulmonary_circulatio | 0.77033779 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.76969617 |
| 114 | MP0003763_abnormal_thymus_physiology | 0.75902239 |
| 115 | MP0000372_irregular_coat_pigmentation | 0.75646045 |
| 116 | MP0002398_abnormal_bone_marrow | 0.74764955 |
| 117 | MP0002722_abnormal_immune_system | 0.72926369 |
| 118 | MP0005535_abnormal_body_temperature | 0.69355716 |
| 119 | MP0005410_abnormal_fertilization | 0.68726324 |
| 120 | MP0005647_abnormal_sex_gland | 0.68218667 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.68201593 |
| 122 | MP0005084_abnormal_gallbladder_morpholo | 0.66981216 |
| 123 | MP0005379_endocrine/exocrine_gland_phen | 0.66692740 |
| 124 | MP0004147_increased_porphyrin_level | 0.66435430 |
| 125 | MP0001919_abnormal_reproductive_system | 0.66148913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 5.60479954 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 5.49766309 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.32246398 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.99408203 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.89353516 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.70938995 |
| 7 | Glomerulonephritis (HP:0000099) | 4.37555320 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.32704516 |
| 9 | Complement deficiency (HP:0004431) | 3.95947316 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.72070160 |
| 11 | Joint hemorrhage (HP:0005261) | 3.69570775 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.57594896 |
| 13 | Dysostosis multiplex (HP:0000943) | 3.45863053 |
| 14 | Abnormality of complement system (HP:0005339) | 3.44805629 |
| 15 | Recurrent skin infections (HP:0001581) | 3.43615868 |
| 16 | Axonal loss (HP:0003447) | 3.24712959 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.23776221 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.23776221 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.23776221 |
| 20 | Gingivitis (HP:0000230) | 3.15477976 |
| 21 | Myocardial infarction (HP:0001658) | 3.07834494 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 2.99325836 |
| 23 | Spontaneous hematomas (HP:0007420) | 2.97582006 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.87659783 |
| 25 | Nephritis (HP:0000123) | 2.83023374 |
| 26 | Mucopolysacchariduria (HP:0008155) | 2.81480187 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.81480187 |
| 28 | Thick nail (HP:0001805) | 2.80990675 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.79669239 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.79669239 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.79669239 |
| 32 | Myositis (HP:0100614) | 2.79234853 |
| 33 | Disinhibition (HP:0000734) | 2.77826424 |
| 34 | Gingival bleeding (HP:0000225) | 2.77442715 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.75350471 |
| 36 | Obstructive lung disease (HP:0006536) | 2.75350471 |
| 37 | Pustule (HP:0200039) | 2.73414349 |
| 38 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.73135026 |
| 39 | Recurrent fungal infections (HP:0002841) | 2.67438118 |
| 40 | Orchitis (HP:0100796) | 2.67390155 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 2.64460062 |
| 42 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.62772817 |
| 43 | Petechiae (HP:0000967) | 2.62530727 |
| 44 | Xanthomatosis (HP:0000991) | 2.59580561 |
| 45 | Amyloidosis (HP:0011034) | 2.53560731 |
| 46 | Hepatosplenomegaly (HP:0001433) | 2.52589459 |
| 47 | Autoimmune hemolytic anemia (HP:0001890) | 2.51679449 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.51369003 |
| 49 | Optic neuritis (HP:0100653) | 2.51369003 |
| 50 | Loss of speech (HP:0002371) | 2.46923212 |
| 51 | Abnormality of T cell number (HP:0011839) | 2.46737404 |
| 52 | Hemoptysis (HP:0002105) | 2.44011993 |
| 53 | Purpura (HP:0000979) | 2.42872703 |
| 54 | Increased IgM level (HP:0003496) | 2.41935705 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.41709577 |
| 56 | Mutism (HP:0002300) | 2.41547349 |
| 57 | Keratoconjunctivitis (HP:0001096) | 2.40427402 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 2.40052228 |
| 59 | Periodontitis (HP:0000704) | 2.39351597 |
| 60 | Vasculitis (HP:0002633) | 2.37029385 |
| 61 | Intrahepatic cholestasis (HP:0001406) | 2.36808543 |
| 62 | Urticaria (HP:0001025) | 2.36299797 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.35881124 |
| 64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.33986135 |
| 65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.33986135 |
| 66 | Keratoconjunctivitis sicca (HP:0001097) | 2.32844562 |
| 67 | Abnormality of the common coagulation pathway (HP:0010990) | 2.30851904 |
| 68 | Prolonged neonatal jaundice (HP:0006579) | 2.29441253 |
| 69 | Abolished electroretinogram (ERG) (HP:0000550) | 2.24141158 |
| 70 | Conjugated hyperbilirubinemia (HP:0002908) | 2.22298307 |
| 71 | Abnormality of B cell number (HP:0010975) | 2.21618459 |
| 72 | Increased serum ferritin (HP:0003281) | 2.21462933 |
| 73 | Recurrent pneumonia (HP:0006532) | 2.20527431 |
| 74 | Albinism (HP:0001022) | 2.18678289 |
| 75 | Mesangial abnormality (HP:0001966) | 2.18627308 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.17617344 |
| 77 | Epistaxis (HP:0000421) | 2.16569341 |
| 78 | Prostate neoplasm (HP:0100787) | 2.14826949 |
| 79 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.14711313 |
| 80 | Hyperlipoproteinemia (HP:0010980) | 2.14527087 |
| 81 | Pathologic fracture (HP:0002756) | 2.13906099 |
| 82 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.13671142 |
| 83 | Osteomyelitis (HP:0002754) | 2.13440481 |
| 84 | Menorrhagia (HP:0000132) | 2.13225362 |
| 85 | Stomach cancer (HP:0012126) | 2.12976689 |
| 86 | Prolonged bleeding time (HP:0003010) | 2.12198432 |
| 87 | Bone pain (HP:0002653) | 2.11425037 |
| 88 | T lymphocytopenia (HP:0005403) | 2.11127191 |
| 89 | Stomatitis (HP:0010280) | 2.08828245 |
| 90 | Congenital sensorineural hearing impairment (HP:0008527) | 2.07259106 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.06852572 |
| 92 | Polyneuropathy (HP:0001271) | 2.05027988 |
| 93 | Vascular calcification (HP:0004934) | 2.04511607 |
| 94 | Recurrent viral infections (HP:0004429) | 2.04405929 |
| 95 | Encephalitis (HP:0002383) | 2.02997333 |
| 96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.01803718 |
| 97 | Congenital stationary night blindness (HP:0007642) | 2.01529402 |
| 98 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.01202973 |
| 99 | Pancreatic cysts (HP:0001737) | 1.99202078 |
| 100 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.98755121 |
| 101 | Hypercholesterolemia (HP:0003124) | 1.98343973 |
| 102 | Leukocytosis (HP:0001974) | 1.97828512 |
| 103 | Meningitis (HP:0001287) | 1.97062211 |
| 104 | Hematochezia (HP:0002573) | 1.96535414 |
| 105 | Fat malabsorption (HP:0002630) | 1.95938521 |
| 106 | Decreased circulating renin level (HP:0003351) | 1.94540081 |
| 107 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.94398235 |
| 108 | Basal ganglia calcification (HP:0002135) | 1.93285092 |
| 109 | Gangrene (HP:0100758) | 1.92563473 |
| 110 | Peripheral demyelination (HP:0011096) | 1.91725685 |
| 111 | Esophageal varix (HP:0002040) | 1.91054267 |
| 112 | Abnormality of the intrinsic pathway (HP:0010989) | 1.91050496 |
| 113 | Hydroxyprolinuria (HP:0003080) | 1.90695986 |
| 114 | Abnormality of proline metabolism (HP:0010907) | 1.90695986 |
| 115 | Deep venous thrombosis (HP:0002625) | 1.87905124 |
| 116 | Steatorrhea (HP:0002570) | 1.87615181 |
| 117 | Attenuation of retinal blood vessels (HP:0007843) | 1.86943631 |
| 118 | Progressive neurologic deterioration (HP:0002344) | 1.85615238 |
| 119 | Abnormality of the prostate (HP:0008775) | 1.85418202 |
| 120 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.83785885 |
| 121 | Chronic diarrhea (HP:0002028) | 1.83208784 |
| 122 | Hypokinesia (HP:0002375) | 1.83086253 |
| 123 | Anorexia (HP:0002039) | 1.82516168 |
| 124 | Abnormality of the pleura (HP:0002103) | 1.82232091 |
| 125 | Abnormality of T cells (HP:0002843) | 1.81805246 |
| 126 | Metaphyseal irregularity (HP:0003025) | 1.80418744 |
| 127 | Inflammation of the large intestine (HP:0002037) | 1.80072381 |
| 128 | Retinal atrophy (HP:0001105) | 1.79985352 |
| 129 | IgG deficiency (HP:0004315) | 1.79599828 |
| 130 | Recurrent lower respiratory tract infections (HP:0002783) | 1.78748394 |
| 131 | Cardiovascular calcification (HP:0011915) | 1.78187900 |
| 132 | Parakeratosis (HP:0001036) | 1.78002983 |
| 133 | J-shaped sella turcica (HP:0002680) | 1.76645835 |
| 134 | Tetraparesis (HP:0002273) | 1.76607252 |
| 135 | Agitation (HP:0000713) | 1.76598378 |
| 136 | Eosinophilia (HP:0001880) | 1.74979044 |
| 137 | Pulmonary embolism (HP:0002204) | 1.74795639 |
| 138 | Nausea (HP:0002018) | 1.74217457 |
| 139 | Abnormality of the renal cortex (HP:0011035) | 1.74200600 |
| 140 | Abnormal drinking behavior (HP:0030082) | 1.72168314 |
| 141 | Polydipsia (HP:0001959) | 1.72168314 |
| 142 | Thyroiditis (HP:0100646) | 1.70126447 |
| 143 | Progressive visual loss (HP:0000529) | 1.69942525 |
| 144 | Agnosia (HP:0010524) | 1.69858827 |
| 145 | Abnormality of eosinophils (HP:0001879) | 1.69581186 |
| 146 | Hyperventilation (HP:0002883) | 1.68647872 |
| 147 | Inappropriate behavior (HP:0000719) | 1.68529919 |
| 148 | Malnutrition (HP:0004395) | 1.67814139 |
| 149 | Cardiomegaly (HP:0001640) | 1.67370404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.34994262 |
| 2 | IRAK3 | 4.04081206 |
| 3 | MAP3K14 | 3.67829633 |
| 4 | ACVR1B | 3.62502937 |
| 5 | IRAK4 | 3.32693835 |
| 6 | TYK2 | 2.74617018 |
| 7 | TBK1 | 2.53666431 |
| 8 | KIT | 2.49226362 |
| 9 | TLK1 | 2.46230282 |
| 10 | TAOK3 | 2.32823286 |
| 11 | IKBKE | 2.28112367 |
| 12 | RIPK4 | 2.19181556 |
| 13 | INSRR | 2.13113037 |
| 14 | TGFBR2 | 2.10484564 |
| 15 | ERN1 | 2.08064390 |
| 16 | IKBKB | 2.03941223 |
| 17 | EPHB1 | 1.94327133 |
| 18 | TXK | 1.87412879 |
| 19 | MAP4K1 | 1.76398759 |
| 20 | JAK1 | 1.65520920 |
| 21 | CAMKK2 | 1.55956109 |
| 22 | MAP2K6 | 1.54474650 |
| 23 | JAK3 | 1.47981884 |
| 24 | TAOK2 | 1.46817274 |
| 25 | EPHA3 | 1.45019180 |
| 26 | MAP3K11 | 1.44171430 |
| 27 | FGFR4 | 1.43400598 |
| 28 | PIK3CG | 1.42835471 |
| 29 | TEC | 1.41679470 |
| 30 | ZAP70 | 1.38725998 |
| 31 | NEK9 | 1.37774488 |
| 32 | IRAK1 | 1.37696714 |
| 33 | PBK | 1.33958856 |
| 34 | GRK7 | 1.33611871 |
| 35 | MAP3K13 | 1.25600778 |
| 36 | DAPK2 | 1.25403966 |
| 37 | BTK | 1.25041268 |
| 38 | MAPKAPK5 | 1.23125640 |
| 39 | NLK | 1.21771634 |
| 40 | NME2 | 1.20227534 |
| 41 | MST4 | 1.19328166 |
| 42 | PIM2 | 1.18719616 |
| 43 | CSK | 1.18115647 |
| 44 | MAP4K2 | 1.11875461 |
| 45 | MAPKAPK3 | 1.10879591 |
| 46 | BMPR2 | 1.09668586 |
| 47 | LYN | 1.06993345 |
| 48 | PINK1 | 1.06713847 |
| 49 | CHUK | 1.04018031 |
| 50 | SYK | 1.03943454 |
| 51 | ADRBK2 | 1.01019770 |
| 52 | DDR2 | 1.00042820 |
| 53 | CSF1R | 0.97170532 |
| 54 | MST1R | 0.96405016 |
| 55 | HCK | 0.95405531 |
| 56 | NUAK1 | 0.94950589 |
| 57 | IRAK2 | 0.93330835 |
| 58 | TRPM7 | 0.92240923 |
| 59 | PIK3CA | 0.92087622 |
| 60 | BCKDK | 0.90242435 |
| 61 | LCK | 0.89715658 |
| 62 | TAOK1 | 0.88602761 |
| 63 | MAPK15 | 0.87942439 |
| 64 | JAK2 | 0.84132421 |
| 65 | ZAK | 0.83890114 |
| 66 | GRK1 | 0.83411407 |
| 67 | ABL2 | 0.82389525 |
| 68 | CDC42BPA | 0.81613463 |
| 69 | PKN1 | 0.81542079 |
| 70 | MATK | 0.78790471 |
| 71 | TGFBR1 | 0.76548351 |
| 72 | EIF2AK2 | 0.75709360 |
| 73 | STK16 | 0.75264932 |
| 74 | TIE1 | 0.72937179 |
| 75 | MAP3K3 | 0.72136814 |
| 76 | YES1 | 0.70742037 |
| 77 | MAP2K2 | 0.70607307 |
| 78 | GRK6 | 0.70486481 |
| 79 | FRK | 0.67702329 |
| 80 | MAP2K3 | 0.67275966 |
| 81 | ITK | 0.65276742 |
| 82 | ADRBK1 | 0.64215864 |
| 83 | OXSR1 | 0.62310932 |
| 84 | RPS6KA5 | 0.61727257 |
| 85 | PTK6 | 0.61303668 |
| 86 | PIM1 | 0.60112604 |
| 87 | CLK1 | 0.59992847 |
| 88 | KDR | 0.59606979 |
| 89 | SIK1 | 0.54082627 |
| 90 | ABL1 | 0.54017321 |
| 91 | MAP3K5 | 0.53976019 |
| 92 | FES | 0.53859772 |
| 93 | WNK3 | 0.51665502 |
| 94 | FGR | 0.50728280 |
| 95 | PRKCD | 0.50357019 |
| 96 | BMPR1B | 0.49552990 |
| 97 | PRKCQ | 0.48390965 |
| 98 | TNK2 | 0.47080985 |
| 99 | NEK6 | 0.46581387 |
| 100 | MAP3K1 | 0.45969599 |
| 101 | FGFR3 | 0.44895405 |
| 102 | FLT3 | 0.44805361 |
| 103 | MAPKAPK2 | 0.44161823 |
| 104 | WNK4 | 0.43216453 |
| 105 | PDK2 | 0.42931651 |
| 106 | FER | 0.42558347 |
| 107 | MUSK | 0.42539409 |
| 108 | CAMK1D | 0.42021178 |
| 109 | PDK1 | 0.40559111 |
| 110 | MYLK | 0.39592191 |
| 111 | STK39 | 0.39384282 |
| 112 | IGF1R | 0.39379613 |
| 113 | AKT3 | 0.39125514 |
| 114 | MAPK13 | 0.37902497 |
| 115 | CSNK1G3 | 0.37013399 |
| 116 | TESK2 | 0.36105235 |
| 117 | MAPK11 | 0.35547750 |
| 118 | EGFR | 0.35412040 |
| 119 | PRKCE | 0.34628086 |
| 120 | PRKAA2 | 0.34037310 |
| 121 | RPS6KA4 | 0.32899817 |
| 122 | CSNK1A1L | 0.31693007 |
| 123 | MAPK4 | 0.30720967 |
| 124 | MARK3 | 0.30440169 |
| 125 | PTK2B | 0.29842305 |
| 126 | RPS6KA6 | 0.29459831 |
| 127 | CSNK1G2 | 0.29445045 |
| 128 | HIPK2 | 0.28326222 |
| 129 | TNIK | 0.27951217 |
| 130 | MAPK7 | 0.27772561 |
| 131 | GSK3A | 0.26206862 |
| 132 | PRKG2 | 0.24790164 |
| 133 | STK4 | 0.24480979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.98829127 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.86758653 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55566478 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.36969819 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.36631234 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.36301109 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.97139899 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96714407 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.91915245 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84559256 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.83087663 |
| 12 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.79601715 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78094482 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.77475835 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74062216 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70305994 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.62942649 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.59227820 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.56601017 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.52334267 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52269112 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.51505963 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.51335191 |
| 24 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.48549392 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.47831472 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.40432945 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39123540 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.34963543 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.33366571 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.32906174 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.31040373 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30893328 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30663102 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.29587423 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.26432686 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.26157861 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.23962265 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20191676 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.16654051 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.14976371 |
| 41 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.13629053 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.12244305 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.12096956 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10062985 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.09352908 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.08729094 |
| 47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06933016 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05976452 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04800429 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04472798 |
| 51 | Protein export_Homo sapiens_hsa03060 | 1.04341254 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04247208 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.02817947 |
| 54 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97584282 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91979023 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90667065 |
| 57 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.90469174 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89057416 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86591040 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.84827178 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84094300 |
| 62 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.81705408 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 0.81597607 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80180946 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78956704 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78775183 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78207728 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77354290 |
| 69 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.76651460 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.75664750 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74134236 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72656769 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72186891 |
| 74 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71970710 |
| 75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71675323 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71432836 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71247957 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71077176 |
| 79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70274993 |
| 80 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69866047 |
| 81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68864918 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68703754 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.67275305 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67204992 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67055045 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66041219 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65775365 |
| 88 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65524194 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.65468002 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65072391 |
| 91 | Phototransduction_Homo sapiens_hsa04744 | 0.64895152 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64820311 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64162353 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.61271647 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61249407 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61051518 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.60249341 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59186582 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59044456 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53962851 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53569320 |
| 102 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51761007 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.51605150 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49323961 |
| 105 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48675867 |
| 106 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.48604882 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47821464 |
| 108 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46679100 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46488955 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45857135 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45855663 |
| 112 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44088583 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40764408 |
| 114 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39332758 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35257189 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34500736 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.33292870 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30456007 |
| 119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29091238 |
| 120 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29058898 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28221000 |
| 122 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.26834799 |
| 123 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26126823 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24716633 |
| 125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22662556 |

